SEARCH

SEARCH BY CITATION

References

  • Andresen, M.S., Abildgaard, U., Liestol, S., Sandset, P.M., Mowinckel, M.C., Odegaard, O.R., Larsen, M.L. & Diep, L.M. (2004) The ability of three global plasma assays to recognize thrombophilia. Thrombosis Research, 113, 411417.
  • Baglin, T. & Greaves, M. (2002) Rebuttal: is a nihilistic approach to thrombophilia screening justifed. Thrombosis and Haemostasis, 88, 700701.
  • Baglin, T., Luddington, R., Brown, K. & Baglin, C. (2003) Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet, 362, 523526.
  • Beguin, S., Lindhout, T. & Hemker, H.C. (1989) The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin. Thrombosis and Haemostasis, 61, 2529.
  • Beguin, S., Kumar, R., Keularts, I., Seligsohn, U., Coller, B.S. & Hemker, H.C. (1999) Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor. Blood, 93, 564570.
  • Beguin, S., Keularts, I., Al Dieri, R., Bellucci, S., Caen, J. & Hemker, H.C. (2004) Fibrin polymerization is crucial for thrombin generation in platelet-rich plasma in a VWF-GPIb-dependent process, defective in Bernard-Soulier syndrome. Journal of Thrombosis and Haemostasis, 2, 170176.
  • Bevers, E.M., Comfurius, P. & Zwaal, R.F. (1991) Platelet procoagulant activity: physiological significance and mechanisms of exposure. Blood Reviews, 5, 146154.
  • Boisclair, M., Ireland, H. & Lane, D. (1990) Assessment of hypercoagulable states by measurement of activation fragments and peptides. Blood Reviews, 4, 2540.
  • Bostrom, S.L., Hansson, G.F., Kjaer, M. & Sarich, T.C. (2003) Effects of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, and dalteparin on the endogenous thrombin potential in venous blood from healthy male subjects. Blood Coagulation and Fibrinolysis, 14, 457462.
  • Bostrom, S.L., Hansson, G.F., Sarich, T.C. & Wolzt, M. (2004) The inhibitory effect of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, compared with enoxaparin and r-hirudin on ex vivo thrombin generation in human plasma. Thrombosis Research, 113, 8591.
  • Broze Jr, G.J., Warren, L.A., Novotny, W.F., Higuchi, D.A., Girard, J.J. & Miletich, J.P. (1988) The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Blood, 71, 335343.
  • Brummel, K., Paradis, S., Branda, R. & Mann, K. (2001) Oral anticoagulation thresholds. Circulation, 104, 23112317.
  • Brummel, K., Paradis, S., Butenas, S. & Mann, K. (2002) Thrombin functions during tissue factor-induced blood coagulation. Blood, 100, 148152.
  • Brummel-Ziedins, K.E., Pouliot, R.L. & Mann, K.G. (2004) Thrombin generation: phenotypic quantitation. Journal of Thrombosis and Haemostasis, 2, 281288.
  • Butenas, S., van't Veer, C. & Mann, K. (1999) ‘Normal’ thrombin generation. Blood, 94, 21692178.
  • Carr, M.E., Martin, E.J., Kuhn, J.G. & Spiess, B.D. (2003) Onset of force development as a marker of thrombin generation in whole blood: the thrombin generation time (TGT). Journal of Thrombosis and Haemostasis, 1, 19771983.
  • Chantarangkul, V., Clerici, M., Bressi, C., Giesen, P.L. & Tripodi, A. (2003) Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability. Haematologica, 88, 547554.
  • Dargaud, Y., Beguin, S., Lienhart, A., Al Dieri, R., Trzeciak, C., Bordet, J.C., Hemker, H.C. & Negrier, C. (2005) Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thrombosis and Haemostasis, 93, 475480.
  • Eichinger, S., Pabinger, I., Stumpflen, A., Hirschl, M., Bialonczyk, C., Schneider, B., Mannhalter, C., Minar, E., Lechner, K. & Kyrle, P. (1997) The risk of recurrent venous thromboembolism in patients with and without factor V Leiden. Thrombosis and Haemostasis, 77, 624628.
  • Eichinger, S., Minar, E., Bialonczyk, C., Hirschl, M., Quehenberger, P., Schneider, B., Weltermann, A., Wagner, O. & Kyrle, P.A. (2003) d-dimer levels and risk of recurrent venous thromboembolism. Journal of the American Medical Association, 290, 10711074.
  • Fischer, A.M., Tapon-Bretaudiere, J., Bros, A. & Josso, F. (1981) Respective roles of antithrombin III and alpha 2 macroglobulin in thrombin inactivation. Thrombosis and Haemostasis, 45, 5154.
  • Gailani, D. & Broze, G. (1991) Factor XI activation in a revised model of blood coagulation. Science, 253, 909912.
  • Gast, A. & Tschopp, T.B. (1995) Inhibition of extrinsic and intrinsic thrombin generation by a novel synthetic thrombin inhibitor (Ro 46–6240), recombinant hirudin and heparin in human plasma. Blood Coagulation and Fibrinolysis, 6, 553560.
  • Gerotziafas, G.T., Chakroun, T., Depasse, F., Arzoglou, P., Samama, M.M. & Elalamy, I. (2004) The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation. Thrombosis and Haemostasis, 91, 977985.
  • Greaves, M. & Baglin, T. (2000) Laboratory testing for heritable thrombophilia: impact on clinical management of thrombotic disease. British Journal of Haematology, 109, 699703.
  • Griffin, J. (1995) The thrombin paradox. Nature, 378, 337338.
  • He, S., Bremme, K. & Blomback, M. (1999) A laboratory method for determination of overall haemostatic potential in plasma. I. Method design and preliminary results. Thrombosis Research, 96, 145156.
  • Hemker, H. & Beguin, S. (2000) Phenotyping the clotting system. Thrombosis and Haemostasis, 84, 747751.
  • Hemker, H.C., Willems, G.M. & Beguin, S. (1986) A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thrombosis and Haemostasis, 56, 917.
  • Hemker, H.C., Wielders, S., Kessels, H. & Beguin, S. (1993) Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thrombosis and Haemostasis, 70, 617624.
  • Hemker, H., Giesen, P., Al Dieri, R., Regnault, V., de Smedt, E., Wagenvoord, R., Lecompte, T. & Beguin, S. (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiology of Haemostasis and Thrombosis, 33, 415.
  • Herault, J., Peyrou, V., Savi, P., Bernat, A. & Herbert, J. (1998) Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo. Thrombosis and Haemostasis, 79, 383388.
  • Hoffman, M. & Monroe, D. (2001) A cell-based model of hemostasis. Thrombosis and Haemostasis, 85, 958965.
  • Hoffman, M., Monroe, D.M., Oliver, J.A. & Roberts, H.R. (1995) Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Blood, 86, 17941801.
  • Josso, F. & Prou-Wartelle, O. (1965) Interaction of tissue factor and factor VII at the earliest phase of coagulation. Thrombosis Diathesis Haemorrhagica, 17, 3544.
  • Kessels, H., Beguin, S., Andree, H. & Hemker, H. (1994) Measurement of thrombin generation in whole blood- the effect of heparin and aspirin. Thrombosis and Haemostasis, 72, 7883.
  • Kumar, R., Beguin, S. & Hemker, C. (1994) The influence of fibrinogen and fibrin on thrombin generation- evidence for feedback activation of the clotting system by clot bound thrombin. Thrombosis and Haemostasis, 72, 713721.
  • Kumar, R., Beguin, S. & Hemker, C. (1995) The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity. Thrombosis and Haemostasis, 74, 962968.
  • Lawrie, A.S., Gray, E., Leeming, D., Davidson, S.J., Purdy, G., Iampietro, R., Craig, S., Rigsby, P. & Mackie, I.J. (2003) A multicentre assessment of the endogenous thrombin potential using a continuous monitoring amidolytic technique. British Journal of Haematology, 123, 335341.
  • Le Gal, G. & Bounameaux, H. (2004) d-Dimer testing to predict recurrence risk in venous thromboembolism: looking for a useful threshold: a rebuttal. Journal of Thrombosis and Haemostasis, 2, 16701672.
  • Lee, L. & Baglin, T. (1995) Altered platelet-phospholipid dependent thrombin generation in thrombocytosis and thrombocytopenia. British Journal of Haematology, 89, 131136.
  • Lee, L., Jennings, I., Luddington, R. & Baglin, T. (1994) Markers of thrombin and plasmin generation in patients with inherited thrombophilia. Journal of Clinical Pathology, 47, 631634.
  • Luddington, R. & Baglin, T. (2004) Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. Journal of Thrombosis and Haemostasis, 2, 19541959.
  • Macfarlane, R.G. & Biggs, R. (1953) A thrombin generation test; the application in haemophilia and thrombocytopenia. Journal of Clinical Pathology, 6, 38.
  • Mann, K., Brummel, K. & Butenas, S. (2003) What is all that thrombin for? Journal of Thrombosis and Haemostasis, 1, 15041514.
  • Mann, K.G., Brummel-Ziedins, K., Undas, A. & Butenas, S. (2004) Does the genotype predict the phenotype? Evaluations of the hemostatic proteome. Journal of Thrombosis and Haemostasis, 2, 17271734.
  • Mannucci, P. (2002) The measurement of multifactorial thrombophilia. Thrombosis and Haemostasis, 88, 12.
  • Marchetti, G., Ferraresi, P., Legnani, C., Pinotti, M., Lunghi, B., Scapoli, C., Gemmati, D., Coccheri, S., Palareti, G. & Bernardi, F. (2003) Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster. British Journal of Haematology, 121, 632638.
  • Middeldorp, S., Meinardi, J.R., Koopman, M.M., van Pampus, E.C., Hamulyak, K., van Der Meer, J., Prins, M.H. & Buller, H.R. (2001) A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism. Annals of Internal Medicine, 135, 322327.
  • O'Donnell, J., Riddell, A., Owens, D., Handa, A., Pasi, J., Hamilton, G. & Perry, D.J. (2004) Role of the Thrombelastograph as an adjunctive test in thrombophilia screening. Blood Coagulation and Fibrinolysis, 15, 207211.
  • Osterud, B. & Rapaport, S. (1977) Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proceedings of the National Academy of Sciences of the USA, 74, 52605264.
  • Palareti, G., Legnani, C., Cosmi, B., Guazzaloca, G., Pancani, C. & Coccheri, S. (2002) Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thrombosis and Haemostasis, 87, 712.
  • Palareti, G., Legnani, C., Cosmi, B., Valdre, L., Lunghi, B., Bernardi, F. & Coccheri, S. (2003) Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation, 108, 313318.
  • Pitney, W.R. & Dacie, J.V. (1953) A simple method of studying the generation of thrombin in recalcified plasma; application in the investigation of haemophilia. Journal of Clinical Pathology, 6, 914.
  • Rand, M., Lock, J., van't Veer, C., Gaffney, D. & Mann, K. (1996) Blood clotting in minimally altered whole blood. Blood, 88, 34223445.
  • Rao, L.V. & Rapaport, S.I. (1987) Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. Blood, 69, 645651.
  • Regnault, V., Hemker, H.C., Wahl, D. & Lecompte, T. (2004) Phenotyping the haemostatic system by thrombography–potential for the estimation of thrombotic risk. Thrombosis Research, 114, 539545.
  • Rintelen, C., Pabinger, I., Knobl, P., Lechner, K. & Mannhalter, C. (1996) Probability of recurrence of thrombosis in patients with and without factor V Leiden. Thrombosis and Haemostasis, 75, 229232.
  • Shima, M., Matsumoto, T., Fukuda, K., Kubota, Y., Tanaka, I., Nishiya, K., Giles, A.R. & Yoshioka, A. (2002) The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C). Thrombosis and Haemostasis, 87, 436441.
  • Siegemund, T., Petros, S., Siegemund, A., Scholz, U. & Engelmann, L. (2003) Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasma. Thrombosis and Haemostasis, 90, 781786.
  • Simioni, P., Tormene, D., Prandoni, P., Zerbinati, P., Gavasso, S., Cefalo, P. & Girolami, A. (2002) Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study. Blood, 99, 19381942.
  • Tejidor, L., Fischer, T., Doobay, H., Givens, T., Manares, C., Carroll, T., Luddington, R. & Baglin, T. (2001) Assessment of global coagulability and hemostatic potential using waveform analysis on the MDA system. Thrombosis and Haemostasis, 86 (Suppl.), P2896.
  • Turecek, P.L., Varadi, K., Keil, B., Negrier, C., Berntorp, E., Astermark, J., Bordet, J.C., Morfini, M., Linari, S. & Schwarz, H.P. (2003) Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay. Pathophysiology of Haemostasis and Thrombosis, 33, 1622.
  • Vanschoonbeek, K., Feijge, M.A., Van Kampen, R.J., Kenis, H., Hemker, H.C., Giesen, P.L. & Heemskerk, J.W. (2004) Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation in thrombogram characteristics. Journal of Thrombosis and Haemostasis, 2, 476484.
  • Varadi, K., Negrier, C., Berntorp, E., Astermark, J., Bordet, J.C., Morfini, M., Linari, S., Schwarz, H.P. & Turecek, P.L. (2003) Monitoring the bioavailability of FEIBA with a thrombin generation assay. Journal of Thrombosis and Haemostasis, 1, 23742380.
  • Weitz, J., Hudoba, M., Massel, D., Maraganore, J. & Hirsh, J. (1990) Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin-III independent inhibitors. Journal of Clinical Investigation, 86, 385391.
  • Wielders, S., Mukherjee, M., Michiels, J., Rijkers, D.T., Cambus, J.P., Knebel, R.W., Kakkar, V., Hemker, H.C. & Beguin, S. (1997) The routine determination of the endogenous thrombin potential, first results in different forms of hyper- and hypocoagulability. Thrombosis and Haemostasis, 77, 629636.